Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin ten Haaf

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
JAMA Oncology|October 21, 2021
Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer ScreeningIakovos Toumazis, Koen de Nijs, Pianpian Cao, et al.
International Journal of Cancer|January 11, 2017
The impact of overdiagnosis on the selection of efficient lung cancer screening strategiesSummer S Han, Kevin Ten Haaf, William D Hazelton, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 13, 2024
The Impact of Model Assumptions on Personalized Lung Cancer Screening RecommendationsKevin Ten Haaf, Koen de Nijs, Giulia Simoni, et al.
Annals of Internal Medicine|February 6, 2023
Risk Model-Based Lung Cancer Screening : A Cost-Effectiveness AnalysisIakovos Toumazis, Pianpian Cao, Koen de Nijs, et al.
JNCI Cancer Spectrum|June 1, 2022
Racial and Ethnic Disparities in Lung Cancer Screening by the 2021 USPSTF Guidelines Versus Risk-Based Criteria: The Multiethnic Cohort StudyJacqueline V Aredo, Eunji Choi, Victoria Y Ding, et al.
Thorax|December 29, 2018
Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening studyJoan E Walter, Marjolein A Heuvelmans, Kevin Ten Haaf, et al.
The Lancet. Oncology|October 6, 2014
Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancersNanda Horeweg, Ernst Th Scholten, Pim A de Jong, et al.
The Lancet. Oncology|June 11, 2016
Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trialJoan E Walter, Marjolein A Heuvelmans, Pim A de Jong, et al.
Cancer|March 1, 2014
Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trialsRafael Meza, Kevin ten Haaf, Chung Yin Kong, et al.
The Lancet. Oncology|October 6, 2014
Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screeningNanda Horeweg, Joost van Rosmalen, Marjolein A Heuvelmans, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
JAMA Oncology|October 21, 2021
Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer ScreeningIakovos Toumazis, Koen de Nijs, Pianpian Cao, et al.
International Journal of Cancer|January 11, 2017
The impact of overdiagnosis on the selection of efficient lung cancer screening strategiesSummer S Han, Kevin Ten Haaf, William D Hazelton, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 13, 2024
The Impact of Model Assumptions on Personalized Lung Cancer Screening RecommendationsKevin Ten Haaf, Koen de Nijs, Giulia Simoni, et al.
Annals of Internal Medicine|February 6, 2023
Risk Model-Based Lung Cancer Screening : A Cost-Effectiveness AnalysisIakovos Toumazis, Pianpian Cao, Koen de Nijs, et al.
JNCI Cancer Spectrum|June 1, 2022
Racial and Ethnic Disparities in Lung Cancer Screening by the 2021 USPSTF Guidelines Versus Risk-Based Criteria: The Multiethnic Cohort StudyJacqueline V Aredo, Eunji Choi, Victoria Y Ding, et al.
Thorax|December 29, 2018
Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening studyJoan E Walter, Marjolein A Heuvelmans, Kevin Ten Haaf, et al.
The Lancet. Oncology|October 6, 2014
Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancersNanda Horeweg, Ernst Th Scholten, Pim A de Jong, et al.
The Lancet. Oncology|June 11, 2016
Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trialJoan E Walter, Marjolein A Heuvelmans, Pim A de Jong, et al.
Cancer|March 1, 2014
Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trialsRafael Meza, Kevin ten Haaf, Chung Yin Kong, et al.
The Lancet. Oncology|October 6, 2014
Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screeningNanda Horeweg, Joost van Rosmalen, Marjolein A Heuvelmans, et al.
Pageof 6